Full-Length NAD + -I Riboswitches Bind a Single Cofactor but Cannot Discriminate against Adenosine Triphosphate
Biochemistry · 2023
DOI: 10.1021/acs.biochem.3c00391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, 2023. Verfasst von Yoshita Srivastava und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Biophysics and Center for RNA Biology, University of Rochester School of Medicine & Dentistry, Rochester, New York 14642…. Hauptthemen laut MEDLINE: Riboswitch. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Biophysics and Center for RNA Biology, University of Rochester School of Medicine & Dentistry, Rochester, New York 14642, United States.
ORCID-Profile: Joseph E Wedekind
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Srivastava, Y., Blau, M. E., Jenkins, J. L., & Wedekind, J. E. (2023). Full-Length NAD + -I Riboswitches Bind a Single Cofactor but Cannot Discriminate against Adenosine Triphosphate. Biochemistry. https://doi.org/10.1021/acs.biochem.3c00391
Vancouver
Srivastava Y, Blau ME, Jenkins JL, Wedekind JE. Full-Length NAD + -I Riboswitches Bind a Single Cofactor but Cannot Discriminate against Adenosine Triphosphate. Biochemistry. 2023. doi:10.1021/acs.biochem.3c00391
BibTeX
@article{Srivastava2023,
author = {Srivastava, Yoshita and Blau, Maya E and Jenkins, Jermaine L and Wedekind, Joseph E},
title = {Full-Length NAD + -I Riboswitches Bind a Single Cofactor but Cannot Discriminate against Adenosine Triphosphate},
journal = {Biochemistry},
year = {2023},
doi = {10.1021/acs.biochem.3c00391}
}
EUVIMED